287 related articles for article (PubMed ID: 26434610)
21. Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China.
Su L; Yin X; Cheng J; Cai Y; Wu D; Feng Z; Liu L
Clin Chim Acta; 2018 Nov; 486():142-150. PubMed ID: 30048636
[TBL] [Abstract][Full Text] [Related]
22. CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants.
Simonetti L; Bruque CD; Fernández CS; Benavides-Mori B; Delea M; Kolomenski JE; Espeche LD; Buzzalino ND; Nadra AD; Dain L
Hum Mutat; 2018 Jan; 39(1):5-22. PubMed ID: 29035424
[TBL] [Abstract][Full Text] [Related]
23. [Contemporary diagnosis and therapy in women with congenital adrenal hyperplasia].
Maciejewska-Jeske M; Meczekalski B
Pol Merkur Lekarski; 2013 Nov; 35(209):297-9. PubMed ID: 24575652
[TBL] [Abstract][Full Text] [Related]
24. Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia.
Wang W; Han R; Yang Z; Zheng S; Li H; Wan Z; Qi Y; Sun S; Ye L; Ning G
J Steroid Biochem Mol Biol; 2021 Jul; 211():105899. PubMed ID: 33864926
[TBL] [Abstract][Full Text] [Related]
25. Testicular adrenal rest tumours in boys, adolescents and adult men with congenital adrenal hyperplasia may be associated with the CYP21A2 mutation.
Mouritsen A; Jørgensen N; Main KM; Schwartz M; Juul A
Int J Androl; 2010 Jun; 33(3):521-7. PubMed ID: 19531083
[TBL] [Abstract][Full Text] [Related]
26. [Congenital adrenal hyperplasia].
Stanić M; Nesović M
Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
[TBL] [Abstract][Full Text] [Related]
27. Impact of molecular genetics on congenital adrenal hyperplasia management.
Balsamo A; Baldazzi L; Menabò S; Cicognani A
Sex Dev; 2010 Sep; 4(4-5):233-48. PubMed ID: 20639616
[TBL] [Abstract][Full Text] [Related]
28. Erroneous prenatal diagnosis of congenital adrenal hyperplasia owing to a duplication of the CYP21A2 gene.
Lekarev O; Tafuri K; Lane AH; Zhu G; Nakamoto JM; Buller-Burckle AM; Wilson TA; New MI
J Perinatol; 2013 Jan; 33(1):76-8. PubMed ID: 23269230
[TBL] [Abstract][Full Text] [Related]
29. Simple virilising congenital adrenal hyperplasia in monozygotic twins: A rare report and review of previous cases.
Muthuvel B; Gautam A; Pal R; Panigrahi I; Dayal D
Pediatr Endocrinol Diabetes Metab; 2020; 26(1):58-62. PubMed ID: 32272826
[TBL] [Abstract][Full Text] [Related]
30. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
31. The molecular basis and genotype-phenotype correlations of congenital adrenal hyperplasia (CAH) in Anatolian population.
Dundar A; Bayramov R; Onal MG; Akkus M; Dogan ME; Kenanoglu S; Cerrah Gunes M; Kazimli U; Ozbek MN; Ercan O; Yildirim R; Celmeli G; Parlak M; Dundar I; Hatipoglu N; Unluhizarci K; Akalin H; Ozkul Y; Saatci C; Dundar M
Mol Biol Rep; 2019 Aug; 46(4):3677-3690. PubMed ID: 31006099
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Forest MG
Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
[TBL] [Abstract][Full Text] [Related]
33. Genetics of congenital adrenal hyperplasia.
Krone N; Arlt W
Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):181-92. PubMed ID: 19500762
[TBL] [Abstract][Full Text] [Related]
34. Molecular defects of the CYP21A2 gene in Greek-Cypriot patients with congenital adrenal hyperplasia.
Skordis N; Kyriakou A; Tardy V; Ioannou YS; Varvaresou A; Dracopoulou-Vabouli M; Patsalis PC; Shammas C; Neocleous V; Phylactou LA
Horm Res Paediatr; 2011; 75(3):180-6. PubMed ID: 20838032
[TBL] [Abstract][Full Text] [Related]
35. Genotype-phenotype correlation in CAH patients with severe CYP21A2 point mutations in the Republic of Macedonia.
Anastasovska V; Kocova M
J Pediatr Endocrinol Metab; 2010 Sep; 23(9):921-6. PubMed ID: 21175091
[TBL] [Abstract][Full Text] [Related]
36. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.
Parsa AA; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):2-11. PubMed ID: 27380651
[TBL] [Abstract][Full Text] [Related]
37. Congenital adrenal hyperplasia with homozygous and heterozygous mutations: a rare family case report.
Cheng T; Liu J; Sun W; Song G; Ma H
BMC Endocr Disord; 2022 Mar; 22(1):57. PubMed ID: 35255871
[TBL] [Abstract][Full Text] [Related]
38. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.
Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
Endokrynol Pol; 2010; 61(1):142-55. PubMed ID: 20205117
[TBL] [Abstract][Full Text] [Related]
39. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
40. A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia.
Anastasovska V; Kocova M; Zdraveska N; Stojiljkovic M; Skakic A; Klaassen K; Pavlovic S
Endocrine; 2021 Jul; 73(1):196-202. PubMed ID: 33715135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
